Improving Resection Rates Among African Americans With NSCLC
This is a randomized, interventional trial in which the navigation is the intervention. Phase is not applicable. The study is a randomized trial to evaluate the impact of a nurse-led patient navigation intervention in improving rates of receipt of lung-directed therapy with curative intent (LDTCI) among African Americans with early stage lung cancer. Study sites are cluster-randomized to either the usual care study arm or the to the navigation intervention study arm. Randomization occurred at the level of the study site rather than at the level of individual participants. There are two arms.
Checked against the public recordLast updated May 12, 2020 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Health Services Research
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- Wake Forest University Health Sciences
- Interventions being studied
- Other: Usual Care; Other: Intervention Arm
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * AA race * Clinically suspicious or biopsy-proven, early stage NSCLC, and * Ages 21 years and older Exclusion Criteria: * Previous history of lung cancer * Spread of newly diagnosed probably/proven lung cancer to other part of the body * Diagnosis of synchronous cancer other than non-melanoma skin cancer or lung cancer, and * Receipt of surgical resection or radiosurgery for lung cancer since diagnosis with probable/proven lung cancer
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Beebe Healthcare Tunnell Cancer CenterLewes, Delaware
- Saint Joseph's/Candler HospitalSavannah, Georgia
- Stroger Hospital of Cook CountyChicago, Illinois
- Ochsner NCORPNew Orleans, Louisiana
- Beaumont Hospital - Royal OakRoyal Oak, Michigan
- Metro-Minnesota NCORPSaint Louis Park, Minnesota
- Nevada Cancer Research FoundationLas Vegas, Nevada
- Wake Forest University Health SciencesWinston-Salem, North Carolina
- Fox ChasePhiladelphia, Pennsylvania
- Virginia Commonwealth UniversityRichmond, Virginia
Source and freshness
Processed from ClinicalTrials.gov. Last public update: May 12, 2020. Always confirm current availability with the study team.